Hsp70-and Hsp90-Mediated Regulation of the Conformation of p53 DNA Binding Domain and p53 Cancer Variants

被引:79
|
作者
Boysen, Marta [1 ,2 ]
Kityk, Roman [1 ]
Mayer, Matthias P. [1 ]
机构
[1] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany
[2] AbbVie Deutschland GmbH & Co KG, Knollstr 50, D-67061 Ludwigshafen, Germany
关键词
MUTANT P53; WILD-TYPE; CORE DOMAIN; MOLECULAR CHAPERONES; STRUCTURAL BASIS; PROTEIN; RESCUE; HSP90; PHOSPHORYLATION; IDENTIFICATION;
D O I
10.1016/j.molcel.2019.03.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activity of the tumor suppressor p53 has to be timed and balanced closely to prevent untimely induction of cell death. The stability of p53 depends on the ubiquitin ligase Mdm2 but also on Hsp70 and Hsp90 chaperones that interact with its DNA binding domain (DBD). Using hydrogen exchange mass spectrometry and biochemical methods, we analyzed conformational states of wild-type p53-DBD at physiological temperatures and conformational perturbations in three frequent p53 cancer mutants. We demonstrate that the Hsp70/Hdj1 system shifts the conformational equilibrium of p53 toward a flexible, more mutant-like, DNA binding inactive state by binding to the DNA binding loop. The analyzed cancer mutants are likewise destabilized by interaction with the Hsp70/Hdj1 system. In contrast, Hsp90 protects the DBD of p53 wild-type and mutant proteins from unfolding. We propose that the Hsp70 and Hsp90 chaperone systems assume complementary functions to optimally balance conformational plasticity with conformational stability.
引用
收藏
页码:831 / +
页数:17
相关论文
共 50 条
  • [1] The conformation of the P450-oxygenase domain of NO-synthase controls the Hsp70-and Hsp90-mediated ubiquitination of the enzyme
    Osawa, Yoichi
    Peng, Hwei-Ming
    Clapp, Kelly M.
    Lau, Miranda
    Barry, Robert L.
    Morishima, Yoshihiro
    DRUG METABOLISM REVIEWS, 2011, 43 : 24 - 24
  • [2] REGULATION OF THE HUMAN HSP70 PROMOTER BY P53
    AGOFF, SN
    HOU, J
    LINZER, DIH
    WU, B
    SCIENCE, 1993, 259 (5091) : 84 - 87
  • [3] Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus
    Galigniana, MD
    Harrell, JM
    O'Hagen, HM
    Ljungman, M
    Pratt, WB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22483 - 22489
  • [4] HSP70 binding sites in the tumor suppressor protein p53
    Fourie, AM
    Hupp, TR
    Lane, DP
    Sang, BC
    Barbosa, MS
    Sambrook, JF
    Gething, MJH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) : 19471 - 19479
  • [5] p53反式结合hsp90β基因
    陈丽玲
    吴宁华
    沈珝琲
    关新民
    中国医学科学院学报, 2002, (03) : 285 - 288
  • [6] Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes
    Kaur, J
    Srivastava, A
    Ralhan, R
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (06) : 609 - 613
  • [7] A Novel Protein Interaction between Nucleotide Binding Domain of Hsp70 and p53 Motif
    Elengoe, Asita
    Abu Naser, Mohammed
    Hamdan, Salehhuddin
    INTERNATIONAL JOURNAL OF GENOMICS, 2015, 2015
  • [8] Overexpression of p53, HSP70 and proliferation activity in oral cancer
    Maruoka, Y
    Yokoo, E
    Ando, T
    Sangu, Y
    Ogiuchi, H
    ORAL ONCOLOGY, VOL V, 1997, : 375 - 378
  • [9] Regulation of cutaneous heat shock protein 70 (HSP70) expression by p53
    Trotter, MJ
    Quenneville, LA
    Li, HY
    Zhou, X
    Tron, VA
    LABORATORY INVESTIGATION, 1999, 79 (01) : 64A - 64A
  • [10] Cloning the P53 DNA Binding Domain
    Jones, Janae
    Faustino, Vroniqa
    Nogaj, Luiza
    FASEB JOURNAL, 2018, 32 (01):